Placebo (N = 18) | CLM (N = 14) | p value | ||
---|---|---|---|---|
Mean ± SD | ||||
Blood glucose | Baseline | 117.00 ± 7.85 | 122.14 ± 7.94 | 0.0702& |
after 6 weeks | 116.78 ± 16.1 | 110.07 ± 16.85 | ||
Difference | -0.22 ± 16.30 | -12.07 ± 15.00 | 0.0432* | |
p-value** | 0.9546 | 0.0100 | ||
after 12 weeks | 117.83 ± 18.29 | 108.86 ± 19.02 | ||
Difference | 0.83 ± 16.19 | -13.29 ± 15.74 | 0.0191* | |
p-value** | 0.8297 | 0.0076 | ||
Insulin | Baseline | 8.37 ± 3.80 | 10.16 ± 5.35 | 0.2768* |
after 6 weeks | 7.92 ± 5.17 | 8.05 ± 6.17 | ||
Difference | -0.45 ± 6.21 | -2.11 ± 5.27 | 0.4032& | |
p-value** | 0.7622 | 0.1582 | ||
after 12 weeks | 9.75 ± 10.08 | 5.41 ± 3.98 | 0.0238& | |
Difference | 1.38 ± 8.86 | -4.74 ± 4.87 | ||
p-value** | 0.5166 | 0.0030 | ||
C-peptide | Baseline | 2.53 ± 1.01 | 2.61 ± 1.05 | 0.8150* |
after 6 weeks | 2.31 ± 1.03 | 2.24 ± 1.01 | ||
Difference | -0.22 ± 0.94 | -0.37 ± 0.81 | 0.6273* | |
p-value** | 0.3428 | 0.1080 | ||
after 12 weeks | 2.58 ± 1.78 | 1.98 ± 0.72 | ||
Difference | 0.05 ± 1.13 | -0.63 ± 0.95 | 0.0752* | |
p-value** | 0.8366 | 0.0263 | ||
HOMA- IR | Baseline | 2.44 ± 1.19 | 3.03 ± 1.57 | 0.2375* |
after 6 weeks | 2.32 ± 1.84 | 2.25 ± 1.79 | ||
Difference | -0.13 ± 2.18 | -0.78 ± 1.65 | 0.3568* | |
p-value** | 0.8075 | 0.0983 | ||
after 12 weeks | 3.14 ± 3.77 | 1.49 ± 1.17 | ||
Difference | 0.69 ± 3.36 | -1.54 ± 1.66 | 0.0159& | |
p-value** | 0.3940 | 0.0042 | ||
HOMA-IR by C-peptide | Baseline | 4.00 ± 1.82 | 4.22 ± 1.59 | 0.5062& |
after 6 weeks | 3.72 ± 2.16 | 3.33 ± 1.61 | ||
Difference | -0.28 ± 2.01 | -0.89 ± 1.56 | 0.3543* | |
p-value** | 0.5647 | 0.0520 | ||
after 12 weeks | 4.35 ± 3.76 | 2.92 ± 1.32 | ||
Difference | 0.35 ± 2.41 | -1.31 ± 1.90 | 0.0289& | |
p-value** | 0.5425 | 0.0232 |